{"id":23489,"date":"2021-06-21T09:26:16","date_gmt":"2021-06-21T08:26:16","guid":{"rendered":"https:\/\/touchneurology.com\/?post_type=media_gallery&p=23489"},"modified":"2021-06-21T09:32:50","modified_gmt":"2021-06-21T08:32:50","slug":"stephanie-nahas-ahs-2021-results-from-the-cameo-study","status":"publish","type":"media_gallery","link":"https:\/\/touchneurology.com\/headache-disorders\/conference-hub\/stephanie-nahas-ahs-2021-results-from-the-cameo-study\/","title":{"rendered":"Stephanie Nahas, AHS 2021: Results from the CaMEO Study"},"content":{"rendered":"
We had the great pleasure of meeting with Stephanie Nahas<\/strong> (Thomas Jefferson University, Jefferson Headache Center, Philadelphia, PA, USA) to discuss the CaMEO results, a web-based survey to characterize self-reported use of preventive medications for migraine and treatment gaps.<\/p>\n The abstract \u2018Characterizing preventive treatment gaps in migraine: Results from the CaMEO study\u2019 & \u2018Optimal acute treatment is associated with productivity gains in people with migraine: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study\u2019 was presented at the American Headache Society (AHS) Virtual Annual Scientific Meeting 2021, 3-6 June 2021.<\/p>\n Questions<\/strong>:<\/p>\n Disclosures<\/strong>: Stephanie Nahas has been on the advisory board for Allergen\/AbbVie, Zosano, Nesos Corp (formerly Vorso Corp); speaker for Allergan\/AbbVie, Amgen\/Novartis, Biohaven, Eli Lilly, Impel, Nesos Corp (formerly Vorso Corp), and has received clinical trial principal investigator support for Teva. Stephanie Nahas is also on the editorial board for Springer (Current Pain and Headache Reports), Wolters-Kluwer (UpToDate), and Neurology Learning Network.<\/p>\n Support<\/strong>: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.<\/p>\n Filmed as a highlight of AHS Virtual Annual Scientific Meeting 2021.<\/strong><\/em><\/p>\n","protected":false},"excerpt":{"rendered":" We had the great pleasure of meeting with Stephanie Nahas (Thomas Jefferson University, Jefferson Headache Center, Philadelphia, PA, USA) to discuss the CaMEO results, a web-based survey to characterize self-reported use of preventive medications for migraine and treatment gaps. The abstract \u2018Characterizing preventive treatment gaps in migraine: Results from the CaMEO study\u2019 & \u2018Optimal acute […]<\/p>\n","protected":false},"featured_media":23490,"template":"","class_list":["post-23489","media_gallery","type-media_gallery","status-publish","has-post-thumbnail","hentry","vocabulary_1-headache-disorders","video_categories-ahs-highlights"],"acf":[],"_links":{"self":[{"href":"https:\/\/touchneurology.com\/wp-json\/wp\/v2\/media_gallery\/23489","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/touchneurology.com\/wp-json\/wp\/v2\/media_gallery"}],"about":[{"href":"https:\/\/touchneurology.com\/wp-json\/wp\/v2\/types\/media_gallery"}],"version-history":[{"count":2,"href":"https:\/\/touchneurology.com\/wp-json\/wp\/v2\/media_gallery\/23489\/revisions"}],"predecessor-version":[{"id":23494,"href":"https:\/\/touchneurology.com\/wp-json\/wp\/v2\/media_gallery\/23489\/revisions\/23494"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/touchneurology.com\/wp-json\/wp\/v2\/media\/23490"}],"wp:attachment":[{"href":"https:\/\/touchneurology.com\/wp-json\/wp\/v2\/media?parent=23489"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n